Matt Larew
Stock Analyst at William Blair
(4.15)
# 1,629
Out of 4,463 analysts
182
Total ratings
55.6%
Success rate
10.6%
Average return
Main Sectors:
Stocks Rated by Matt Larew
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| TECH Bio-Techne | Downgraded: Hold | n/a | $71.00 | - | 8 | Jun 27, 2026 | |
| TMO Thermo Fisher Scientific | Reiterated: Buy | n/a | $513.33 | - | 10 | Jun 12, 2026 | |
| STVN Stevanato Group | Maintained: Buy | n/a | $18.34 | - | 11 | Jun 10, 2026 | |
| OPCH Option Care Health | Maintained: Buy | n/a | $21.04 | - | 12 | Jun 1, 2026 | |
| TWST Twist Bioscience | Reiterated: Buy | n/a | $102.25 | - | 10 | May 26, 2026 | |
| WST West Pharmaceutical Services | Maintained: Buy | n/a | $365.00 | - | 11 | May 20, 2026 | |
| RGEN Repligen | Maintained: Buy | n/a | $138.99 | - | 9 | May 14, 2026 | |
| MXCT MaxCyte | Maintained: Hold | n/a | $1.23 | - | 9 | May 13, 2026 | |
| DNA Ginkgo Bioworks Holdings | Reiterated: Sell | n/a | $10.28 | - | 12 | May 11, 2026 | |
| TXG 10x Genomics | Maintained: Buy | n/a | $39.05 | - | 9 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $6.15 | - | 13 | May 8, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $5.88 | - | 8 | May 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $8.88 | - | 13 | May 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $378.13 | - | 5 | May 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Rated: Hold | $119 | $125.25 | -4.99% | 12 | May 1, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Hold | n/a | $10.01 | - | 8 | Apr 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $193.72 | - | 8 | Apr 22, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | n/a | $229.09 | - | 1 | Oct 11, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | n/a | $71.31 | n/a | 4 | Oct 8, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $16.40 | n/a | 1 | Aug 22, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $11.71 | n/a | 2 | Sep 22, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Hold | n/a | $228.03 | n/a | 4 | Sep 11, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Maintained: Buy | n/a | $283.88 | n/a | 1 | Dec 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | n/a | $101.39 | n/a | 1 | Nov 21, 2017 |
Bio-Techne
Jun 27, 2026
Downgraded: Hold
Price Target: n/a
Current: $71.00
Upside: -
Thermo Fisher Scientific
Jun 12, 2026
Reiterated: Buy
Price Target: n/a
Current: $513.33
Upside: -
Stevanato Group
Jun 10, 2026
Maintained: Buy
Price Target: n/a
Current: $18.34
Upside: -
Option Care Health
Jun 1, 2026
Maintained: Buy
Price Target: n/a
Current: $21.04
Upside: -
Twist Bioscience
May 26, 2026
Reiterated: Buy
Price Target: n/a
Current: $102.25
Upside: -
West Pharmaceutical Services
May 20, 2026
Maintained: Buy
Price Target: n/a
Current: $365.00
Upside: -
Repligen
May 14, 2026
Maintained: Buy
Price Target: n/a
Current: $138.99
Upside: -
MaxCyte
May 13, 2026
Maintained: Hold
Price Target: n/a
Current: $1.23
Upside: -
Ginkgo Bioworks Holdings
May 11, 2026
Reiterated: Sell
Price Target: n/a
Current: $10.28
Upside: -
10x Genomics
May 8, 2026
Maintained: Buy
Price Target: n/a
Current: $39.05
Upside: -
May 8, 2026
Maintained: Hold
Price Target: n/a
Current: $6.15
Upside: -
May 7, 2026
Maintained: Buy
Price Target: n/a
Current: $5.88
Upside: -
May 6, 2026
Reiterated: Buy
Price Target: n/a
Current: $8.88
Upside: -
May 5, 2026
Maintained: Buy
Price Target: n/a
Current: $378.13
Upside: -
May 1, 2026
Rated: Hold
Price Target: $119
Current: $125.25
Upside: -4.99%
Apr 29, 2026
Maintained: Hold
Price Target: n/a
Current: $10.01
Upside: -
Apr 22, 2026
Maintained: Buy
Price Target: n/a
Current: $193.72
Upside: -
Oct 11, 2025
Upgraded: Buy
Price Target: n/a
Current: $229.09
Upside: -
Oct 8, 2024
Reiterated: Hold
Price Target: n/a
Current: $71.31
Upside: n/a
Aug 22, 2022
Maintained: Buy
Price Target: n/a
Current: $16.40
Upside: n/a
Sep 22, 2021
Downgraded: Hold
Price Target: n/a
Current: $11.71
Upside: n/a
Sep 11, 2019
Downgraded: Hold
Price Target: n/a
Current: $228.03
Upside: n/a
Dec 3, 2018
Maintained: Buy
Price Target: n/a
Current: $283.88
Upside: n/a
Nov 21, 2017
Initiated Coverage: Buy
Price Target: n/a
Current: $101.39
Upside: n/a